Entero Healthcare Solutions Share Price
1633.10+51.70 (+3.27%)
+47.90% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
ADANIENTNSE
CPPLUSNSE
AEGISLOGNSE
PREMIERENENSE
REDINGTONNSE
HONASANSE
SGMARTNSE
LLOYDSENTNSE
MMTCNSE
EBGNGNSE
ENTERONSE
Entero Healthcare Solutions Share Price
1633.10+51.70 (+3.27%)
+47.90% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 30% | 26% | 29% |
| - | - | - | 36% |
| - | - | - | 43% |
| 3% | 4% | 7% | 9% |
Peer Comparison
Symbol
ADANIENT
CPPLUS
AEGISLOG
PREMIERENE
REDINGTON
HONASA
SGMART
LLOYDSENT
MMTC
EBGNG
ENTERO
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 2,674 | ₹350614 Cr | 61.1 | 11.02 | 97.19 | ₹9339 Cr |
| 3,921.7 | ₹47512 Cr | 99.55 | 12.07 | 43.68 | ₹368 Cr |
| 1,162.5 | ₹41427 Cr | 31.1 | 7.42 | 44.04 | ₹898 Cr |
| 893.8 | ₹40352 Cr | 24.23 | 10.2 | 45.28 | ₹1510 Cr |
| 341.6 | ₹26217 Cr | 15.41 | 6.22 | 24.36 | ₹1490 Cr |
| 463.8 | ₹14914 Cr | 59.93 | 2.77 | 8.99 | ₹200 Cr |
| 899.9 | ₹11187 Cr | 73.69 | 4.28 | 13.3 | ₹111 Cr |
| 61.62 | ₹9247 Cr | 82.35 | 0.38 | 0.91 | ₹283 Cr |
| 53.22 | ₹7839 Cr | 17.52 | 0.69 | 3.01 | ₹387 Cr |
| 752.2 | ₹7827 Cr | 47.12 | 4.94 | 15.72 | ₹132 Cr |
| 1,633.1 | ₹6875 Cr | 54.82 | 8.77 | 39.51 | ₹115 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹1940 Cr | ₹1910 Cr | ₹1707 Cr | ₹1571 Cr | ₹1404 Cr | ₹1339 Cr | ₹1359 Cr | ₹1301 Cr | ₹1097 Cr | ₹1034 Cr | ₹993 Cr | ₹996 Cr | ₹899 Cr | ₹887 Cr | ₹829 Cr |
| ₹3 Cr | ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹6 Cr | ₹7 Cr | ₹7 Cr | ₹11 Cr | ₹13 Cr | ₹9 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹58 L | ₹2 Cr |
| ₹1944 Cr | ₹1914 Cr | ₹1711 Cr | ₹1576 Cr | ₹1410 Cr | ₹1346 Cr | ₹1366 Cr | ₹1312 Cr | ₹1110 Cr | ₹1043 Cr | ₹994 Cr | ₹998 Cr | ₹901 Cr | ₹888 Cr | ₹831 Cr |
| ₹1856 Cr | ₹1839 Cr | ₹1649 Cr | ₹1519 Cr | ₹1363 Cr | ₹1299 Cr | ₹1317 Cr | ₹1266 Cr | ₹1073 Cr | ₹1012 Cr | ₹970 Cr | ₹974 Cr | ₹879 Cr | ₹874 Cr | ₹816 Cr |
| ₹100 Cr | ₹90 Cr | ₹72 Cr | ₹67 Cr | ₹56 Cr | ₹56 Cr | ₹58 Cr | ₹54 Cr | ₹44 Cr | ₹38 Cr | ₹30 Cr | ₹31 Cr | ₹27 Cr | ₹21 Cr | ₹21 Cr |
| ₹21 Cr | ₹17 Cr | ₹14 Cr | ₹12 Cr | ₹11 Cr | ₹10 Cr | ₹10 Cr | ₹11 Cr | ₹10 Cr | ₹17 Cr | ₹16 Cr | ₹18 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr |
| ₹67 Cr | ₹58 Cr | ₹40 Cr | ₹45 Cr | ₹36 Cr | ₹37 Cr | ₹39 Cr | ₹35 Cr | ₹27 Cr | ₹14 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹98 L | ₹2 Cr |
| ₹52 Cr | ₹45 Cr | ₹34 Cr | ₹37 Cr | ₹30 Cr | ₹31 Cr | ₹29 Cr | ₹26 Cr | ₹21 Cr | ₹21 Cr | ₹7 Cr | ₹5 Cr | ₹6 Cr | -₹4 Cr | ₹4 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Long-Term Borrowings
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| — | — | — | — | — | — |
| ₹44 Cr | ₹44 Cr | ₹43 Cr | ₹668 Cr | ₹623 Cr | ₹517 Cr |
| ₹6 Cr | ₹4 Cr | ₹2 Cr | ₹0 | ₹0 | ₹0 |
| ₹1639 Cr | ₹1676 Cr | ₹1593 Cr | -₹73 Cr | -₹62 Cr | -₹32 Cr |
| ₹1639 Cr | ₹1676 Cr | ₹1593 Cr | -₹73 Cr | -₹62 Cr | -₹32 Cr |
| ₹1689 Cr | ₹1724 Cr | ₹1638 Cr | ₹595 Cr | ₹561 Cr | ₹485 Cr |
| ₹64 Cr | ₹46 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹37 Cr | ₹0 |
| ₹100 Cr | ₹0 | ₹46 Cr | ₹31 Cr | ₹37 Cr | ₹0 |
| ₹23 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| -₹54 Cr | -₹14 Cr | -₹19 Cr | -₹1 Cr | ₹1 Cr | ₹1 Cr |
| ₹116 Cr | ₹78 Cr | ₹49 Cr | ₹50 Cr | ₹58 Cr | ₹53 Cr |
| ₹22 Cr | ₹10 Cr | ₹7 Cr | ₹5 Cr | ₹4 Cr | ₹3 Cr |
| ₹206 Cr | ₹73 Cr | ₹83 Cr | ₹85 Cr | ₹100 Cr | ₹57 Cr |
| — | — | — | — | — | — |
| ₹725 Cr | ₹397 Cr | ₹230 Cr | ₹211 Cr | ₹140 Cr | ₹97 Cr |
| ₹397 Cr | ₹138 Cr | ₹135 Cr | ₹67 Cr | ₹65 Cr | ₹30 Cr |
| ₹444 Cr | ₹299 Cr | ₹230 Cr | ₹342 Cr | ₹248 Cr | ₹142 Cr |
| ₹21 Cr | ₹11 Cr | ₹7 Cr | ₹4 Cr | ₹9 Cr | ₹20 Cr |
| ₹1588 Cr | ₹845 Cr | ₹602 Cr | ₹624 Cr | ₹462 Cr | ₹289 Cr |
| ₹3546 Cr | ₹2688 Cr | ₹2326 Cr | ₹1307 Cr | ₹1125 Cr | ₹833 Cr |
| ₹6 Cr | ₹4 Cr | ₹35 L | ₹30 L | ₹1 L | ₹31 L |
| ₹567 Cr | ₹299 Cr | ₹276 Cr | ₹374 Cr | ₹285 Cr | ₹142 Cr |
| — | — | — | — | — | — |
| ₹1129 Cr | ₹686 Cr | ₹383 Cr | ₹339 Cr | ₹311 Cr | ₹218 Cr |
| ₹171 Cr | ₹127 Cr | ₹94 Cr | ₹71 Cr | ₹49 Cr | ₹30 Cr |
| ₹958 Cr | ₹559 Cr | ₹289 Cr | ₹268 Cr | ₹262 Cr | ₹189 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹59 L | ₹0 |
| ₹72 Cr | ₹47 Cr | ₹20 Cr | ₹14 Cr | ₹12 Cr | ₹10 Cr |
| ₹5 Cr | ₹6 Cr | ₹5 Cr | ₹1 Cr | ₹0 | ₹0 |
| ₹1038 Cr | ₹613 Cr | ₹315 Cr | ₹284 Cr | ₹274 Cr | ₹201 Cr |
| — | — | — | — | — | — |
| ₹130 Cr | ₹58 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹842 Cr | ₹660 Cr | ₹421 Cr | ₹342 Cr | ₹310 Cr | ₹244 Cr |
| ₹1212 Cr | ₹830 Cr | ₹615 Cr | ₹515 Cr | ₹375 Cr | ₹242 Cr |
| ₹162 Cr | ₹260 Cr | ₹893 Cr | ₹107 Cr | ₹105 Cr | ₹83 Cr |
| ₹89 Cr | ₹66 Cr | ₹41 Cr | ₹23 Cr | ₹24 Cr | ₹32 Cr |
| ₹68 Cr | ₹201 Cr | ₹41 Cr | ₹37 Cr | ₹36 Cr | ₹32 Cr |
| ₹2503 Cr | ₹2076 Cr | ₹2011 Cr | ₹1023 Cr | ₹851 Cr | ₹633 Cr |
| ₹916 Cr | ₹1231 Cr | ₹1409 Cr | ₹399 Cr | ₹389 Cr | ₹344 Cr |
| ₹3546 Cr | ₹2688 Cr | ₹2326 Cr | ₹1307 Cr | ₹1125 Cr | ₹833 Cr |
| ₹387 | ₹395 | ₹376 | -₹167 | -₹151 | -₹3,175 |
| ₹387 | ₹395 | ₹376 | -₹167 | -₹151 | -₹3,175 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| ₹179 Cr | ₹139 Cr | ₹36 Cr | -₹4 Cr | -₹20 Cr | -₹11 Cr |
| ₹107 Cr | ₹44 Cr | ₹87 Cr | ₹71 Cr | ₹42 Cr | ₹43 Cr |
| -₹136 Cr | -₹222 Cr | -₹146 Cr | -₹100 Cr | -₹46 Cr | -₹96 Cr |
| ₹150 Cr | -₹39 Cr | -₹24 Cr | -₹33 Cr | -₹24 Cr | -₹64 Cr |
| ₹96 Cr | -₹77 Cr | -₹37 Cr | -₹45 Cr | -₹35 Cr | -₹69 Cr |
| -₹303 Cr | ₹220 Cr | -₹705 Cr | -₹49 Cr | -₹162 Cr | -₹31 Cr |
| ₹124 Cr | -₹74 Cr | ₹863 Cr | ₹73 Cr | ₹211 Cr | ₹89 Cr |
| -₹83 Cr | ₹69 Cr | ₹121 Cr | -₹21 Cr | ₹14 Cr | -₹11 Cr |
| ₹229 Cr | ₹148 Cr | ₹25 Cr | ₹47 Cr | ₹32 Cr | ₹43 Cr |
| ₹80 L | ₹12 Cr | ₹1 Cr | ₹0 | ₹0 | ₹0 |
| ₹147 Cr | ₹229 Cr | ₹148 Cr | ₹25 Cr | ₹47 Cr | ₹32 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found
Entero Healthcare Solutions Share Price
1633.10+51.70 (+3.27%)
+47.90% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 4 out of 9 oscillators
RSI
53.56Neutral
STOCH %K
94.85Sell
MACD Level(12,26)
-25.13Sell
Ultimate Oscillator
63.44Buy
Aroon Oscillator
24.00Sell
BOP
0.41Buy
CCI
47.40Neutral
Williams %R
-5.15Sell
Momentum
41.40Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 8
Bearish signals: 1 out of 9 moving averages
EMA 9
1578.91Buy
SMA 9
1560.12Buy
EMA 21
1596.78Buy
SMA 21
1587.87Buy
EMA 50
1595.62Buy
SMA 50
1694.42Sell
EMA 200
1392.07Buy
SMA 200
1313.86Buy
WMA 20
1564.47Buy
Pivot
Pivot
Classic
Resistance 5
1719.17
Resistance 4
1684.07
Resistance 3
1648.97
Resistance 2
1613.87
Resistance 1
1597.63
Pivot
1578.77
Support 1
1562.53
Support 2
1543.67
Support 3
1508.57
Support 4
1473.47
Support 5
1438.37
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Entero Healthcare Solutions Share Price
1633.10+51.70 (+3.27%)
+47.90% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 52.40% | 52.40% | 52.42% | 52.42% | 52.42% | 52.42% |
| 5.76% | 4.37% | 4.04% | 5.14% | 14.68% | 17.21% |
| 10.01% | 6.51% | 7.10% | 6.17% | 4.86% | 4.05% |
| 11.15% | 8.97% | 9.52% | 10.25% | 4.78% | 6.14% |
| 20.68% | 27.75% | 26.92% | 26.02% | 23.26% | 20.18% |
Bulk & block deals
Name
Prasid Uno Family Trust
Hdfc Mutual Fund
Prasid Uno Family Trust
Prasid Unofamily Trust
Hdfc Mutual Fund
Prasid Uno Family Trust
Prasid Uno Family Trust
Prasid Uno Family Trust
3P India Equity Fund 1
3P India Equity Fund 1M
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 18 Sep 2026 | Sell | 207.10 Cr | ₹1,695 | 12.22 L | Bulk | 2.807291 | NSE |
| 18 Sep 2026 | Purchase | 235.60 Cr | ₹1,695 | 13.90 L | Bulk | 3.193706 | NSE |
| 18 Sep 2026 | Sell | 207.10 Cr | ₹1,695 | 12.22 L | Block | 2.807291 | NSE |
| 18 Sep 2026 | Sell | 28.51 Cr | ₹1,695 | 1.68 L | Block | 0.386415 | NSE |
| 18 Sep 2026 | Purchase | 235.60 Cr | ₹1,695 | 13.90 L | Block | 3.193706 | NSE |
| 17 Sep 2026 | Sell | 55.93 Cr | ₹1,694.97 | 3.30 L | Bulk | 0.758218 | BSE |
| 17 Sep 2026 | Sell | 69.41 Cr | ₹1,692.98 | 4.10 L | Bulk | 0.942028 | NSE |
| 24 Aug 2026 | Sell | 149.97 Cr | ₹1,377.80 | 10.88 L | Bulk | 2.500971 | BSE |
| 24 Aug 2026 | Purchase | 104.99 Cr | ₹1,377.80 | 7.62 L | Block | 1.750794 | BSE |
| 24 Aug 2026 | Purchase | 44.99 Cr | ₹1,377.80 | 3.27 L | Block | 0.750176 | BSE |
Insider trading & SAST
Client name
Icici Prudential Mutual Fund
Icici Prudential Mutual Fund
Smallcap World Fund, Inc.
Gic Pvt Ltd
Smallcap World Fund, Inc.
Invesco Mutual Fund
Surbhi Singh Prasad Uno Family Trust
Jayant Prakash
Jayant Prakash
Abhitsh Kumar
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29 May 2026 | Other | Disposal | 2.85 | 2.16 | 0 | — | 12.42 L | 30 Dec 2025 - 21 May 2026 | Market | 9,40,428 | SAST | 29(2) | — |
| 12 Jan 2026 | Other | Acquisition | 5.01 | 5.01 | 0 | — | 21.82 L | 29 Dec 2025 | Market | 21,82,039 | SAST | 29(1) | — |
| 12 Jan 2026 | — | Disposal | 5.23 | — | 0 | — | 22.77 L | 29 Dec 2025 | Market | — | SAST | 29(2) | — |
| 13 Aug 2025 | Other | Disposal | 0.02 | 3.14 | 0 | — | 9.85 K | 11 Aug 2025 | Market | 13,66,561 | SAST | 29(2) | — |
| 28 Jan 2025 | — | Acquisition | 0.23 | 5.23 | 0 | — | 1.04 L | 23 Jan 2025 | Market | 22,77,083 | SAST | 29(1) | — |
| 17 Jan 2025 | Other | Acquisition | 0.07 | 5 | 0 | — | 31.60 K | 09 Jan 2025 | Market | 21,76,018 | SAST | 29(1) | — |
| 21 Oct 2024 | Other | Disposal | 5.52 | 0.23 | 0 | — | 24 L | 27 Sep 2024 | Market | 1,00,000 | SAST | 29(2) | — |
| 30 Aug 2024 | KMP | Disposal | 0.00501 | 0 | 28.81 L | ₹1,321.98 | 2.18 K | 29 Aug 2024 | Market Sale | 2,314 | Insider Trading | — | Equity Shares |
| 22 Aug 2024 | KMP | Disposal | 0.003104 | 0.01 | 17.75 L | ₹1,315 | 1.35 K | 21 Aug 2024 | Market Sale | 4,493 | Insider Trading | — | Equity Shares |
| 20 Aug 2024 | Designated Person | Disposal | 0.002759 | 0.03 | 15.39 L | ₹1,282.72 | 1.20 K | 19 Aug 2024 | Market Sale | 13,471 | Insider Trading | — | Equity Shares |
Entero Healthcare Solutions Share Price
1633.10+51.70 (+3.27%)
+47.90% past 1 Year
Entero Healthcare Solutions Limited is one of India's largest and fastest growing healthcare products distribution platforms. The company offers both demand generation and demand fulfilment solutions to healthcare product manufacturers.
Corporate Actions
Date
Type
Details
Company details
Entero Healthcare Solutions Share Price
1633.10+51.70 (+3.27%)
+47.90% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Entero Healthcare Solutions Share Price
1633.10+51.70 (+3.27%)
+47.90% past 1 Year
News
Entero Healthcare sees Rs 94.06 crore NSE block trade at Rs 1,695
Equity
ENTERO
Entero Healthcare Solutions reports higher Q1 EBITDA and margin expansion
Equity
ENTERO
Entero Healthcare Solutions reports Q1 revenue growth to Rs 1,940 crores
Equity
ENTERO
Entero Healthcare Solutions reports higher Q1 net profit year on year
Equity
ENTERO
Entero Healthcare Solutions informs about resignation of director
Equity
ENTERO
Jefferies raises Entero Healthcare Solutions target price, reiterates Buy call
Equity
ENTERO
Entero Healthcare Solutions gets nod to acquire Vishal Surgicals, Vishal Surgicals & Medicals
Equity
ENTERO
Entero Healthcare Solutions reports strong Q4 EBITDA growth and margin expansion
Equity
ENTERO
Entero Healthcare posts strong Q4 profit and revenue growth year-on-year
Equity
ENTERO
Entero Healthcare reports Profit after tax of 13.42 Crores, in the March 2026 quarter
Equity
ENTERO
Entero Healthcare Solutions Reports Q3FY26 EBITDA Growth to Rs 67.80 Crores, Margin at 3.97%.
Equity
ENTERO
Entero Healthcare Solutions Q3FY26 Consolidated Net Profit Rises 9% YoY to Rs 27.60 Crores, Revenue Up 26% to Rs 1710 Crores.
Equity
ENTERO
Entero Healthcare reports Profit after tax of 80.50 Lakhs, in the December 2025 quarter
Equity
ENTERO
Entero Healthcare Acquires 51% Stake in Anand Chemiceutics for INR 2.3 Billion
Equity
ENTERO
Entero Healthcare soars on acquiring majority stake in Anand Chemiceutics
Equity
ENTERO
Entero Healthcare acquires majority stake in Anand Chemiceutics
Equity
ENTERO
Entero Healthcare Solutions submits analyst meet intimation
Equity
ENTERO
Entero Healthcare Solutions: Atreja's Drug License Temporarily Banned for Three Days.
Equity
ENTERO
Entero Healthcare Solutions informs about change of name of statutory auditor
Equity
ENTERO
Jefferies upgrades Entero Healthcare Solutions to buy, raises target to Rs 1320
Equity
ENTERO